Last reviewed · How we verify
NCT04239495: MASS_LC
Muscle Ageing Sarcopenia Study Lifecourse (MASS Lifecourse)
trial testing Observational study: range of clinical and lifestyle factors in Sarcopenia in 160 participants. Status unknown.
1 October 2020
Quick facts
| Lead sponsor | Newcastle-upon-Tyne Hospitals NHS Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 160 |
| Start date | 9 October 2018 |
| Primary completion | 1 October 2020 |
| Estimated completion | 31 March 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Observational study: range of clinical and lifestyle factors
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
Sponsor
Newcastle-upon-Tyne Hospitals NHS Trust
Who can join
Adults 45 to 85, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sarcopenia is the loss of muscle mass and function with age. It has been recognised as an important health problem because it is common in older adults and associated with decline in physical function as well as a reduced quality of life. Sarcopenia can also lead to serious health consequences in terms of increased disability and the need for increased health and social care. There is considerable interest in understanding what causes sarcopenia in order to develop new approaches to prevention, diagnosis and treatment. To gain a detailed understanding of sarcopenia across a range of ages, we have designed the Muscle Ageing Sarcopenia Study (MASS\_Lifecourse) in collaboration with members of the public and patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Determining the feasibility of characterising cellular senescence in human skeletal muscle and exploring associations with muscle morphology and physical function at different ages: findings from the MASS_Lifecourse Study.
Habiballa L, Hruby A, Granic A, Dodds RM, et al · · 2024 · cited 8× · PMID 37434081 · DOI 10.1007/s11357-023-00869-4
Verify or expand the search:
- PubMed search for NCT04239495
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Other Newcastle-upon-Tyne Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT05874739 — Mobilise-D: Extension Study · recruiting
- NCT06978985 — Adult SMA Research and Clinical Hub · recruiting
- NCT04239287 — Preterm Lung Function and Exercise Response Measured by OEP · unknown
- NCT05366101 — Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy · Phase 2, PHASE3 · completed
- NCT04194463 — Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04239495 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Newcastle-upon-Tyne Hospitals NHS Trust
- Last refreshed: 27 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04239495.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing